Medindia

X

Simcere Pharmaceutical Group Reports Unaudited First Quarter 2011 Results

Wednesday, May 11, 2011 General News J E 4
Advertisement

SIMCERE PHARMACEUTICAL GROUP

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

(AMOUNTS EXPRESSED IN THOUSANDS)

December 31,

March 31,

March 31,

2010

2011

2011

RMB

RMB

USD

Assets

Current assets

Cash, cash equivalents and restricted cash

278,716

236,012

36,042

Accounts and bills receivable, net

884,738

942,417

143,918

Inventories

89,732

101,501

15,500

Other current assets

135,301

146,385

22,354

Total current assets

1,388,487

1,426,315

217,814

Property, plant and equipment, net

866,262

869,947

132,851

Land use rights

142,910

142,109

21,702

Goodwill and intangible assets, net

658,139

649,971

99,258

Investments in and advance to affiliated companies

121,220

118,491

18,095

Other assets

41,234

40,928

6,250

Total assets

3,218,252

3,247,761

495,970

Liabilities

Current liabilities

Short-term borrowings and current portion of long-term borrowings

360,000

499,950

76,348

Accounts payable

49,638

46,226

7,059

Other payables and accrued liabilities

596,208

487,102

74,386

Total current liabilities

1,005,846

1,033,278

157,793

Long-term borrowings, excluding current portion

19,306

-

-

Deferred tax liabilities

68,811

63,079

9,633

Other liabilities

22,593

22,851

3,490

Total liabilities

1,116,556

1,119,208

170,916

Redeemable noncontrolling interest

47,453

48,504

7,407

Shareholders' equity

Simcere shareholders' equity

Ordinary shares at par

8,597

8,604

1,314

Additional paid-in capital

948,469

955,777

145,958

Accumulated other comprehensive loss

(97,512)

(98,968)

(15,114)

Retained earnings

1,019,118

1,047,008

159,890

Total equity attributable to Simcere

1,878,672

1,912,421

292,048

Noncontrolling interest

175,571

167,628

25,599

Total shareholders' equity

2,054,243

2,080,049

317,647

Commitments and contingencies

Total liabilities, redeemable noncontrolling interest and shareholders' equity

3,218,252

3,247,761

495,970

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Reportlinker Adds Production and Market of Glyoxyl...
S
Gravity Defying High Tech Ultrasound Therapy for N...